Summary
The situation of clinical research in Europe must be improved substantially according to statements of scientists, managers and politicians. The analysis of requirements is available; however, there are no indications that the conclusion of the analysis is being converted into actual facts. Government programs, although originally conceived to improve the situation of clinical research, are used to maintain the status quo. The European Research Network on Surgical Infections (EURESI) concept has been developed by scientists and clinicians from European institutions and university hospitals to make the first steps possible in a new cooperation in European research. With regard to the essentials for clinical research, formulated according to a survey among research-oriented pharmaceutical companies, EURESI was successful in the following objectives: 1) competence in clinical research, 2) capacity for clinical studies, 3) internal quality control, 4) special know-how relevant to clinical studies, 5) performance according to a time plan, 6) interdisciplinianism, 7) contract partnership, 8) organization of research meetings. This special addendum includes presentations at the EURESI meeting in Heidelberg/Weinheim with special reference to the requirements for clinical studies in intraabdominal infections to further stimulate contact with the network.
Similar content being viewed by others
References
Gallin, J. I., Smits, H. L.: Managing the interface between medical schools, hospitals, and clinical research. JAMA 277 (1997) 651–654.
Baumbauer, E.: Klinische Arzneimittelforschung in Deutschland—Eine Standortbestimmung aus Sicht der Industrie. Langenbecks. Arch. Chir. Suppl. II (1996) 646–650.
Ramsch, K. D.: Experiences with GCP in the pharmaceutical industry. Methods Find. Exp. Clin. Pharmacol. 15 (1993) 237–240.
Hannisdal, E.: Clinical research in a hospital—from the lone rider to teamwork. Acta Oncol. 35 (1996) (Suppl. 8) 35–39.
Holzheimer, R. G.: Klinische Forschung in Deutschland— Universität und Industrie als gleichwertige Partner? In:Hollerith, J. (ed.): Leistungsfähige Hochschulen—aber wie? Luchterhand. Neuwied 1997, pp. 111–119.
Ebert, K., Krebs, R.: Interaktion der industriellen und akademischen Forschung in der Bundesrepublik am Beispiel der Pharmaindustrie. In:Hollerith, J. (ed.): Leistungsfähige Hochschulen—aber wie? Luchterhand, Neuwied 1997, pp. 157–174.
Schwarz, R. P.: Maintaining integrity and credibility in industry-sponsored clinical research. Controled Clin. Trials 12 (1991) 753–760.
Blumenstein, B. A., James, K. E., Lind, B. K., Mitchell, H. E.: Functions and organization of coordinating centers for multicenter studies. Controlled clinical trials. Design, methods, and analysis. Abstr. 16 (1995) 4S-29S.
Holzheimer, R. G.: Fast cytokine analysis as part of a European research network. Shock 8 (Suppl.) (1997) 37.
Holzheimer, R. G., Cavaillon, J. M., Aasen, A. O., Cainzos, M., Schöffel, U.: Clinical routine cytokine determination as part of a European research network. Shock 7 (Suppl.) (1997) 121.
Poy, E.: Objectives of QC systems and QA function in clinical research. Qual. Assur. 2 (1993) 326–331.
Goodson, R. L.: Good clinical practice: past, present, and future. Qual. Assur. 4 (1995) 60–67.
Holzheimer, R. G., Hirte, J. F., Reith, B., Engelhardt, W., Horak, K. H., Leppert, R., Aasen, A., Capel, P., Urbaschek, R., Karch, H., Thiede, A.: Different endotoxin release and IL-6 plasma levels after antibiotic administration in surgical intensive care patients. J. Endotoxin Res. 3 (1996) 261–267.
Holzheimer, R. G., Cavaillon, J. M., Mosca, F., Haupt, W., Stefani, A., DiStefano, R., Torres, A., Capel, P., Aasen, A., Anderson, I., Schoeffel, U.: Clinical and basic science aspects of immune pathogenesis of sepsis and peritonitis. Med. Microbiol. Letters 5 (1996) 386–393.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Holzheimer, R.G. The EURESI project. Infection 26, 323–328 (1998). https://doi.org/10.1007/BF02962265
Issue Date:
DOI: https://doi.org/10.1007/BF02962265